Literature DB >> 24973447

Increased IFN-α-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-α production.

Chang-Qing Xia1, Ruihua Peng1, Anna V Chernatynskaya1, Lihui Yuan1, Carolyn Carter2, John Valentine3, Eric Sobel3, Mark A Atkinson1, Michael J Clare-Salzler4.   

Abstract

Increasing evidence suggests that type 1 IFN (IFN-αβ) is associated with pathogenesis of Th1-mediated type 1 diabetes (T1D). A major source of IFN-αβ is plasmacytoid dendritic cells (pDCs). In this study, we analyzed peripheral blood pDC numbers and functions in at-risk, new-onset, and established T1D patients and controls. We found that subjects at risk for T1D and new-onset and established T1D subjects possessed significantly increased pDCs but similar number of myeloid DCs when compared with controls. pDC numbers were not affected by age in T1D subjects but declined with increasing age in control subjects. It was demonstrated that IFN-α production by PBMCs stimulated with influenza viruses was significantly higher in T1D subjects than in controls, and IFN-α production was correlated with pDC numbers in PBMCs. Of interest, only T1D-associated Coxsackievirus serotype B4 but not B3 induced majority of T1D PBMCs to produce IFN-α, which was confirmed to be secreted by pDCs. Finally, in vitro studies demonstrated IFN-α produced by pDCs augmented Th1 responses, with significantly greater IFN-γ-producing CD4(+) T cells from T1D subjects. These findings indicate that increased pDCs and their IFN-αβ production may be associated with this Th1-mediated autoimmune disease, especially under certain viral infections linked to T1D pathogenesis.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24973447      PMCID: PMC4500116          DOI: 10.4049/jimmunol.1303230

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

Review 1.  Type I interferon as a stimulus for cross-priming.

Authors:  Agnès Le Bon; David F Tough
Journal:  Cytokine Growth Factor Rev       Date:  2008-02       Impact factor: 7.638

2.  IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells.

Authors:  Siyang Liu; Hongjie Wang; Yulan Jin; Robert Podolsky; M V Prasad Linga Reddy; Jennifer Pedersen; Bruce Bode; John Reed; Dennis Steed; Steve Anderson; Ping Yang; Andy Muir; Leigh Steed; Diane Hopkins; Yihua Huang; Sharad Purohit; Cong-Yi Wang; Andrea K Steck; Annalisa Montemari; George Eisenbarth; Marian Rewers; Jin-Xiong She
Journal:  Hum Mol Genet       Date:  2008-10-16       Impact factor: 6.150

Review 3.  Innate immunity and its role in type 1 diabetes.

Authors:  Danny Zipris
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-08       Impact factor: 3.243

4.  High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon alpha for chronic hepatitis C virus infection.

Authors:  Tim C M A Schreuder; Huub C Gelderblom; Christine J Weegink; Dörte Hamann; Henk W Reesink; J Hans Devries; Joost B L Hoekstra; Peter L M Jansen
Journal:  Liver Int       Date:  2007-11-21       Impact factor: 5.828

Review 5.  The accelerator hypothesis and increasing incidence of type 1 diabetes.

Authors:  Spiros Fourlanos; Leonard C Harrison; Peter G Colman
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2008-08       Impact factor: 3.243

6.  Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice.

Authors:  Qing Li; Baohui Xu; Sara A Michie; Kathleen H Rubins; Robert D Schreriber; Hugh O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-20       Impact factor: 11.205

7.  Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function.

Authors:  Garima Garg; Jennifer R Tyler; Jennie H M Yang; Antony J Cutler; Kate Downes; Marcin Pekalski; Gwynneth L Bell; Sarah Nutland; Mark Peakman; John A Todd; Linda S Wicker; Timothy I M Tree
Journal:  J Immunol       Date:  2012-03-28       Impact factor: 5.422

Review 8.  Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE.

Authors:  Ding-Lei Su; Zhi-Min Lu; Min-Ning Shen; Xia Li; Ling-Yun Sun
Journal:  J Biomed Biotechnol       Date:  2012-02-15

9.  Transcriptional signatures as a disease-specific and predictive inflammatory biomarker for type 1 diabetes.

Authors:  H Levy; X Wang; M Kaldunski; S Jia; J Kramer; S J Pavletich; M Reske; T Gessel; M Yassai; M W Quasney; M K Dahmer; J Gorski; M J Hessner
Journal:  Genes Immun       Date:  2012-09-13       Impact factor: 2.676

10.  Plasmacytoid dendritic cells are proportionally expanded at diagnosis of type 1 diabetes and enhance islet autoantigen presentation to T-cells through immune complex capture.

Authors:  Jennifer S Allen; Karl Pang; Ania Skowera; Richard Ellis; Chloe Rackham; Biliana Lozanoska-Ochser; Timothy Tree; R David G Leslie; Jennifer M Tremble; Colin M Dayan; Mark Peakman
Journal:  Diabetes       Date:  2008-10-03       Impact factor: 9.461

View more
  33 in total

1.  Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease.

Authors:  Mark A Atkinson; Matthias von Herrath; Alvin C Powers; Michael Clare-Salzler
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

Review 2.  Interferon alpha: The key trigger of type 1 diabetes.

Authors:  Angela Lombardi; Effie Tsomos; Sara S Hammerstad; Yaron Tomer
Journal:  J Autoimmun       Date:  2018-08-14       Impact factor: 7.094

3.  Modulation of the immune system by the gut microbiota in the development of type 1 diabetes.

Authors:  James A Pearson; Andrew Agriantonis; F Susan Wong; Li Wen
Journal:  Hum Vaccin Immunother       Date:  2018-09-19       Impact factor: 3.452

4.  Upregulation of PD-L1 via HMGB1-Activated IRF3 and NF-κB Contributes to UV Radiation-Induced Immune Suppression.

Authors:  Wei Wang; Nicole M Chapman; Bo Zhang; Mingqi Li; Meiyun Fan; R Nicholas Laribee; M Raza Zaidi; Lawrence M Pfeffer; Hongbo Chi; Zhao-Hui Wu
Journal:  Cancer Res       Date:  2019-02-08       Impact factor: 12.701

Review 5.  Stabilization of high-risk plaques.

Authors:  Kohei Takata; Satoshi Imaizumi; Bo Zhang; Shin-Ichiro Miura; Keijiro Saku
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

Review 6.  Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes.

Authors:  Jessica A Pane; Barbara S Coulson
Journal:  Diabetologia       Date:  2015-03-21       Impact factor: 10.122

Review 7.  Effects of type 1 diabetes-associated IFIH1 polymorphisms on MDA5 function and expression.

Authors:  Benjamin M Looney; Chang-Qing Xia; Patrick Concannon; David A Ostrov; Michael J Clare-Salzler
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

8.  Despite Increased Type 1 IFN, Autoimmune Nonobese Diabetic Mice Display Impaired Dendritic Cell Response to CpG and Decreased Nuclear Localization of IFN-Activated STAT1.

Authors:  M Jubayer Rahman; Gwendoline Rahir; Matthew B Dong; Yongge Zhao; Kameron B Rodrigues; Chie Hotta-Iwamura; Ye Chen; Alan Guerrero; Kristin V Tarbell
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

Review 9.  Innate immunity in latent autoimmune diabetes in adults.

Authors:  Juan Huang; James Alexander Pearson; F Susan Wong; Li Wen; Zhiguang Zhou
Journal:  Diabetes Metab Res Rev       Date:  2021-06-22       Impact factor: 4.876

10.  Plasmacytoid dendritic cells promote acute kidney injury by producing interferon-α.

Authors:  Bo Deng; Yuli Lin; Yusheng Chen; Shuai Ma; Qian Cai; Wenji Wang; Bingji Li; Tingyan Liu; Peihui Zhou; Rui He; Feng Ding
Journal:  Cell Mol Immunol       Date:  2020-01-03       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.